800 patients with rare gene mutation tracked for pancreatic cancer risk
NCT ID NCT07413029
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 800 people who carry a mutation in the PRSS1 gene, which causes hereditary pancreatitis. Researchers will collect health data and questionnaires to track how often pancreatic cancer develops and how the disease progresses over time. The goal is to better understand the natural history of this rare condition and improve future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors better predict pancreatic cancer risk in people with hereditary pancreatitis and improve monitoring guidelines.
What could go wrong
This is an observational study, not a treatment trial. It will not test any new drug or therapy, and results may take years to produce actionable insights.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
REBOURS
RECRUITINGClichy-sous-Bois, France
Contact Phone: •••-•••-•••• Email: •••••@•••••